CYIOS Corporation
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John Fredrick O'Shea
- Full Time Employees
- 15
- Sector
- Financial Services
- Industry
- Financial - Credit Services
- Address
- 258 South Military Trail Deerfield Beach FL United States of America 33442
- IPO Date
- Dec 2, 1998
- Website
- cyioscorporation.com
- Similar Companies
- Business
- CYIOS Corporation (CYIO) is a publicly traded diversified holding company focused on acquiring, operating, and scaling high-growth businesses in the medical supplies, healthcare, technology, blockchain, and AI sectors. The company, founded in 1997 and headquartered in Deerfield Beach, Florida, operates primarily through its subsidiary Noir Medical Supplies, which provides high-quality wholesale medical equipment and supplies including diagnostic tools, consumables, and specialized healthcare products to providers across the United States and the Caribbean; it previously encompassed crypto-currency lending via Helio’s CeFi Aggregator platform, crypto trading through Helio Exchange, NFT minting and trading on Randombly NFT Marketplace, and branded health and wellness products under Choice Wellness such as DR’s CHOICE and 24 brands. CYIOS develops, distributes, and licenses proprietary products while pursuing strategic acquisitions to expand its portfolio in high-growth areas like Web3, carbon offsets, and SaaS platforms. Recent developments include the September 2024 acquisition of Noir Medical Supplies, which generated $4.6 million in 2023 revenue and projects over $7 million in 2024 with positive cash flow extending into 2025; a leadership transition in October 2025 where former CEO David Lewis stepped down, returned preferred shares, and canceled obligations to strengthen the balance sheet; completion of 2024 PCAOB-audited financials with 2023 audits targeted for mid-2025; and the December 2025 appointment of John O’Shea as CEO and Chairman to drive AI/SaaS initiatives including CyioIQ, an AI-driven platform to automate Noir’s operations in procurement, pricing, and analytics while pursuing medical sector acquisitions and joint ventures over 24-36 months. These moves position CYIOS for uplisting, operational efficiency, and expanded revenue streams in the multi-billion-dollar B2B medical supply chain and digital health markets.
CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations
CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors
CYIOS Corp Reports Record $5 Million in Q4 Revenue Through Noir Subsidiary; Noir Full-Year Revenue Exceeds $14.4 Million
CYIOS Corporation Announces it has Closed the Acquisition of Noir Medical Supplies
CYIOS Corp. Shareholder Update: New Carboncred Carbon Offsetting Platform Launch, Supply Partner Offset Projects, and More
CYIOS Corp Partners with Intent Sciences to Drive Branding, SEO, and GTM Strategies for Its Carbon Offset Platform, Carboncred: Targeting the Global Carbon Offsets Market
CYIOS CORP PLEASED TO ANNOUNCE LAUNCHING OF CRYPTO-CURRENCY TRADING EXCHANGE
CYIOS CORP PLEASED TO ANNOUNCE LAUNCHING OF CRYPTO-CURRENCY TRADING EXCHANGE
CYIOS CORP COMPLETES ACQUISITION OF CRYPTO LENDING PLATFORM AND CeFi AGREEGATOR HELIO LENDING
CYIOS Corp. Completes Acquisition of Crypto Lending Platform and CeFi Aggregator, Helio Lending
CYIOS CORP TO ACQUIRE PRIVATELY HELD HELIO LENDING
CYIOS Corp. to Acquire Privately Held Helio Lending
PRIVATELY HELD AUSSIE-BASED HELIO LENDING ANNOUNCES EXPANSION AND HIRING PLANS FOR ITS CRYPTOCURRENCY LENDING PLATFORM
CYIOS CORP'S RECEIVES APPROVAL TO SELL ITS SANITIZER PRODUCTS ON AMAZON.COM
CYIOS Corp. Receives Approval to Sell Its Sanitizer Products on Amazon.com